The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 224 participants.
Also called NCT00784433
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 224 participants
- Sponsor
- Ben-Gurion University of the Negev
- Registry
-
NCT00784433
-
- Other papers using this trial's data
- Differential Effect of Initiating Moderate Red Wine Consumption on 24-h Blood Pressure by Alcohol Dehydrogenase Genotypes: Randomized Trial in Type 2 Diabetes
- Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial
- Effects of initiating moderate wine intake on abdominal adipose tissue in adults with type 2 diabetes: a 2-year randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT00784433. Randomized; no masking; primary purpose prevention. Start 2010-06 (registry gives no type); primary completion 2012-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial
- Acronym
- CASCADE
- Condition
- Diabetes
- Condition
- Prediabetes
- Intervention (Dietary supplement)
- alcohol
- Lead sponsor
- Ben-Gurion University of the Negev
Record details
- Record id
cardio:ct-nct00784433- Content hash
e0eead62b3ea24e23890ef8cadc46e6dfdae18bb9d3e2d015160617503337146